Short-term outcome of mild isolated antenatal hydronephrosis conservatively managed
Autor: | Laura F. Alconcher, María M Tombesi |
---|---|
Rok vydání: | 2011 |
Předmět: |
Male
medicine.medical_specialty Time Factors Urology Urinary system Pregnancy Trimester Third Hydronephrosis urologic and male genital diseases Kidney Ultrasonography Prenatal Diagnosis Differential Pregnancy Antenatal Hydronephrosis medicine Humans Kidney Pelvis Prospective Studies Antibiotic prophylaxis Pregnancy Complications Infectious Prospective cohort study business.industry Ultrasound Infant Newborn Disease Management Infant medicine.disease Prognosis Surgery Child Preschool Pediatrics Perinatology and Child Health Urinary Tract Infections Disease Progression Gestation Female business Follow-Up Studies |
Zdroj: | Journal of pediatric urology. 8(2) |
ISSN: | 1873-4898 |
Popis: | Objectives To assess the outcome of newborns with mild isolated antenatal hydronephrosis (MIAHN) managed with neither antibiotic prophylaxis nor voiding cystourethrography (VCUG). Material and methods Inclusion criteria: anterior-posterior pelvic diameter 5–15 mm at third trimester of gestation, confirmed by first postnatal ultrasound. Exclusion criteria: pelvic diameter > 15 mm, calyectasis, hydroureteronephrosis, renal or bladder abnormalities. Clinical and ultrasound follow-up was performed. Parents were familiarized with urinary tract infection (UTI) signs. If UTI was confirmed, VCUG was performed. Hydronephrosis outcome was assessed as intrauterine resolution, total or partial resolution, stability or progression. Results MIAHN was detected in 193 newborns (109 unilateral, 84 bilateral; 277 renal units); 23 (12%) had UTI and 2 of them showed low-grade reflux. After a mean follow-up of 15 months, 91 renal units showed intrauterine resolution (33%), 111 (40%) total resolution, 20 (7%) partial resolution, 52 (19%) stability and 3 (1%) progression. Conclusion Total resolution of hydronephrosis was observed in 73% of renal units during the first year. Routine antibiotic prophylaxis and VCUG might not be necessary in all infants with MIAHN, clinical and ultrasound follow-up being advisable during the first year of life. |
Databáze: | OpenAIRE |
Externí odkaz: |